Decisions on treatment for leukemia patients are based, among other things, on a series of certain genetic features of the disease. IT specialists and physicians have now shown how a method based on artificial intelligence can be used to predict various genetic features on the basis of high-resolution microscopic images of bone marrow smears.
Read more …Leukemia: Artificial intelligence provides support in diagnostics

More than 65,000 men fall ill with prostate cancer each year in Germany. Twelve thousand of them develop a treatment-resistant form which eventually ends in death. Now, a team of researchers has developed an active substance that might in future represent a new treatment option. This substance, known as KMI169, targets an enzyme that plays an important role in the development of prostate cancer.
Read more …Prostate cancer: Newly-developed inhibitor shows massive potential

More Articles …